carocell biotech



News and Events

Read about our latest research developments and general news here.

Contact us for further information:

uk innovate grant

Innovate UK grant award - July 2020

Carocell Bio have achieved an Innovate UK grant to examine the use of one of their compounds as a new treatment to switch off the inflammation seen after a burn that may lead to a reduction of burn pain and a later reduction of burn scarring.

Dr Mike Davies, Carocell Bio’s CEO said: “This is an exciting project that will start on 1st July 2020 after receiving Innovate UK’s grant offer letter. We will be working with local partners, including Wythenshawe Hospital Burns Unit to deliver the project on time and on budget. This project will deliver exciting results and take Carocell Bio to the next stage showing that our topical medicines work in human tissue.”

BioSeed 2020, London - January 20, 2020

Carocell Bio will be presenting at BioSeed 2020

bioseed 2020

38th J.P. Morgan Healthcare Conference, San Francisco
January 13-16, 2020

Carocell Bio will be attending the 38th J.P Morgan Healthcare Conference


bridge biotec facebookbridge biotec twitterbridge biotec linkedinbridge-youtube-60x60.png


UK: +44 (0) 161 532 8751
US: +1 307 409 5778

USA Office

Carocell Bio, Inc.
Suite 425A
North Carolina Biotechnology Center
15 TW Alexander Drive
Research triangle Park
NC 27709

UK Office

Carocell Bio Ltd.
Brooks Drive
Cheadle Royal Business Park


Copyright Carocell Bio Ltd. ©2021
Please contact Carocell Bio Ltd. if you wish use our logo or content in any way